Reanalysis of gene expression profiles of cd4+ t cells treated with hiv-1 latency reversal agents

Antonio Victor Campos Coelho, Ronald Rodrigues de Moura, Sergio Crovella

Research output: Contribution to journalArticlepeer-review

Abstract

The human immunodeficiency virus (HIV-1) causes a progressive depletion of CD4+ T cells, hampering immune function. Current experimental strategies to fight the virus focus on the reactivation of latent HIV-1 in the viral reservoir to make the virus detectable by the immune system, by searching for latency reversal agents (LRAs). We hypothesize that if common molecular pathways elicited by the presence of LRAs are known, perhaps new, more efficient, “shock-and-kill” strategies can be found. Thus, the objective of the present study is to re-evaluate RNA-Seq assays to find differentially expressed genes (DEGs) during latency reversal via transcriptome analysis. We selected six studies (45 samples altogether: 16 negative controls and 29 LRA-treated CD4+ T cells) and 11 LRA strategies through a systematic search in Gene Expression Omnibus (GEO) and PubMed databases. The raw reads were trimmed, counted, and normalized. Next, we detected consistent DEGs in these independent experiments. AZD5582, romidepsin, and suberanilohydroxamic acid (SAHA) were the LRAs that modulated most genes. We detected 948 DEGs shared by those three LRAs. Gene ontology analysis and cross-referencing with other sources of the literature showed enrichment of cell activation, differentiation and signaling, especially mitogen-activated protein kinase (MAPK) and Rho-GTPases pathways.

Original languageEnglish
Article number1505
Pages (from-to)1-16
Number of pages16
JournalMicroorganisms
Volume8
Issue number10
DOIs
Publication statusPublished - Oct 2020

Keywords

  • Antiretroviral therapy
  • Reservoir
  • RNA-Seq
  • Shock-and-kill
  • Transcriptomics

ASJC Scopus subject areas

  • Microbiology
  • Virology
  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Reanalysis of gene expression profiles of cd4+ t cells treated with hiv-1 latency reversal agents'. Together they form a unique fingerprint.

Cite this